An overview of third, fourth and sixth cranial nerve palsies in the setting of COVID-19: A case report and systematic review.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
09 Dec 2022
09 Dec 2022
Historique:
entrez:
10
1
2023
pubmed:
11
1
2023
medline:
13
1
2023
Statut:
ppublish
Résumé
Covid-19 has serious sequelae that may be poorly understood, underreported, and, as a result, not diagnosed promptly, such as variations in clinical manifestations of hyperinflammation among people infected with SARS-CoV-2. ophthalmoplegia can be one of these manifestations. We are reporting a 55-year-old male patient with unilateral diplopia considering it as a case of multisystem inflammatory syndrome in adults. We also reviewed the literature systematically for the previously reported studies/cases with third, fourth and sixth cranial nerve palsies due to or after Covid-19. The literature search yielded 17 studies reporting 29 patients. 71.4% of the patients were males with a mean age of 42.23 years. Ophthalmological symptoms took 9.7 days to appear after the respiratory involvement. All patients had diplopia as part of their visual symptoms. 41.4% of the patients had unilateral sixth nerve palsy, 24% had bilateral sixth nerve involvement, 17% had fourth nerve involvement, and 27.6% had third nerve involvement. Ophthalmoplegia is considered presenting symptom of Covid-19. Further research is needed to detect all neuro-ophthalmological manifestations of Covid-19.
Sections du résumé
BACKGROUND
BACKGROUND
Covid-19 has serious sequelae that may be poorly understood, underreported, and, as a result, not diagnosed promptly, such as variations in clinical manifestations of hyperinflammation among people infected with SARS-CoV-2. ophthalmoplegia can be one of these manifestations.
METHODS
METHODS
We are reporting a 55-year-old male patient with unilateral diplopia considering it as a case of multisystem inflammatory syndrome in adults. We also reviewed the literature systematically for the previously reported studies/cases with third, fourth and sixth cranial nerve palsies due to or after Covid-19.
RESULTS
RESULTS
The literature search yielded 17 studies reporting 29 patients. 71.4% of the patients were males with a mean age of 42.23 years. Ophthalmological symptoms took 9.7 days to appear after the respiratory involvement. All patients had diplopia as part of their visual symptoms. 41.4% of the patients had unilateral sixth nerve palsy, 24% had bilateral sixth nerve involvement, 17% had fourth nerve involvement, and 27.6% had third nerve involvement.
CONCLUSION
CONCLUSIONS
Ophthalmoplegia is considered presenting symptom of Covid-19. Further research is needed to detect all neuro-ophthalmological manifestations of Covid-19.
Identifiants
pubmed: 36626529
doi: 10.1097/MD.0000000000032023
pii: 00005792-202212090-00043
pmc: PMC9750665
doi:
Types de publication
Case Reports
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e32023Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
N Engl J Med. 1956 Jul 12;255(2):57-65
pubmed: 13334797
J Neurol. 2020 Nov;267(11):3128-3129
pubmed: 32533321
Arq Bras Oftalmol. 2021 Aug 18;85(2):182-185
pubmed: 34431903
JAMA Netw Open. 2021 Sep 01;4(9):e2126456
pubmed: 34550381
J Neuroophthalmol. 2020 Dec;40(4):520-522
pubmed: 32941331
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 25;7(5):
pubmed: 32587102
Arch Soc Esp Oftalmol (Engl Ed). 2020 Jul;95(7):361-362
pubmed: 32517875
Arq Neuropsiquiatr. 2020 Jun;78(6):385-386
pubmed: 32609196
Clin Exp Optom. 2017 Jan;100(1):20-25
pubmed: 27701774
Pediatr Neurol. 1999 Jan;20(1):49-52
pubmed: 10029260
Acta Diabetol. 2009 Mar;46(1):23-6
pubmed: 18758685
BMC Res Notes. 2014 Apr 23;7:264
pubmed: 24758689
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Neurol Sci. 2021 May;42(5):2079-2080
pubmed: 33400067
J AAPOS. 2020 Aug;24(4):216-217
pubmed: 32592761
Neurology. 2020 Aug 4;95(5):221-223
pubmed: 32358218
J Neurovirol. 2020 Dec;26(6):970-972
pubmed: 32910433
Ophthalmology. 2002 Oct;109(10):1925-8
pubmed: 12359616
Am J Case Rep. 2020 Oct 15;21:e925897
pubmed: 33056942
Neurology. 2020 Aug 4;95(5):e601-e605
pubmed: 32303650
J Neuroophthalmol. 2021 Sep 1;41(3):e286-e287
pubmed: 33060468
JAMA Pediatr. 2021 Aug 1;175(8):837-845
pubmed: 33821923
AJNR Am J Neuroradiol. 2020 Jul;41(7):1184-1186
pubmed: 32467190
Neurohospitalist. 2021 Apr;11(2):152-155
pubmed: 33791060
BMJ Case Rep. 2020 Nov 4;13(11):
pubmed: 33148560
Pediatr Neurol. 2021 Feb;115:48-49
pubmed: 33333460
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Colomb Med (Cali). 2020 Sep 30;51(3):e504560
pubmed: 33402757